<DOC>
	<DOCNO>NCT00176410</DOCNO>
	<brief_summary>There evidence degenerative change lead aortic stenosis cause chronic inflammatory process . Furthermore development aortic stenosis partially dependent typical cardiovascular risk factor . An inflammatory process well risk factor amenable medical therapy . As use statin ( HMG CoA reductase inhibitor ) would appeal concept reduce risk development aortic stenosis . Aim study evaluate usefulness statin therapy progression aortic stenosis .</brief_summary>
	<brief_title>Statin Therapy Asymptomatic Aortic Stenosis</brief_title>
	<detailed_description>This study prospective , double-blind , placebo-controlled , two-armed clinical trial trial test influence statin therapy progression calcify aortic stenosis patient asymptomatic mild moderate aortic stenosis . After completion baseline investigation patient randomly assign verum group ( fluvastatin group ) control group ( placebo group ) . Patients verum group receive fluvastatin start dose 40 mg per day . The dose increase 80 mg per day . The treatment continue study end ( 24 month ) . Follow investigation perform 6 , 12 , 18 month . After 24 month final investigation perform .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>1 . Age â‰¥ 21 year 2 . Mild moderate aortic stenosis 3 . No symptom cause aortic stenosis 4 . Written inform consent participate study 5 . Aortic valve leaflet thicken reduce systolic opening 6 . Reduced aortic valve area &gt; 0,8 cm2 &lt; 1,5 cm2 7 . Maximum aortic jet velocity rest &gt; 2,5 m/s 1 . Symptoms cause aortic stenosis 2 . Aortic valve area &lt; 0,7 cm2 3 . Severe aortic regurgitation 4 . Reduced leave ventricular ejection fraction ( &lt; 50 % ) 5 . Any valve disease indication surgery 6 . Coronary artery disease 7 . Therapy refractory arterial hypertension 8 . Comorbid noncardiac disease reason make regular followup impossible 9 . Other indication treatment statins 10 . Women childbearing potential use contraception method ( ) specify study ( specify ) , well woman breastfeed 11 . Known sensitivity study drug ( ) class study drug ( ) 12 . Patients severe medical condition ( ) view investigator prohibit participation study ( specify require ) 13 . Use investigational agent last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>aortic valve stenosis</keyword>
	<keyword>statin therapy</keyword>
</DOC>